Bank of America
CARM

Bank of America’s Carisma Therapeutics CARM Stock Holding History

Bank of America’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,398
Closed -$383 – 7462
2025
Q3 		$383 Buy
1,398
+63
+5% +$21 ﹤0.01% 7627
2025
Q2 		$522 Sell
1,335
-5,952
-82% -$1.59K ﹤0.01% 7659
2025
Q1 		$2.26K Buy
7,287
+10
+0.1% +$4 ﹤0.01% 7322
2024
Q4 		$3.04K Sell
7,277
-4
-0.1% -$3 ﹤0.01% 7151
2024
Q3 		$7.14K Sell
7,281
-34,988
-83% -$37.9K ﹤0.01% 6951
2024
Q2 		$64.2K Buy
42,269
+20,745
+96% +$30.9K ﹤0.01% 6436
2024
Q1 		$48.9K Sell
21,524
-22,296
-51% -$53.6K ﹤0.01% 6519
2023
Q4 		$128K Sell
43,820
-10,689
-20% -$31.8K ﹤0.01% 6275
2023
Q3 		$231K Buy
54,509
+11,019
+25% +$69.7K ﹤0.01% 5824
2023
Q2 		$381K Buy
43,490
+43,109
+11,315% +$235K ﹤0.01% 5455
2023
Q1 		$1.18K Sell
381
-940
-71% -$8.95K ﹤0.01% 7282
2022
Q4 		$16.1K Hold
1,321
– – ﹤0.01% 6805
2022
Q3 		$11K Buy
1,321
+1,185
+871% +$16.1K ﹤0.01% 7204
2022
Q2 		$2K Sell
136
-742
-85% -$8.49K ﹤0.01% 7764
2022
Q1 		$11K Sell
878
-1,141
-57% -$15.9K ﹤0.01% 7701
2021
Q4 		$33K Buy
2,019
+547
+37% +$11K ﹤0.01% 7368
2021
Q3 		$23K Sell
1,472
-294
-17% -$14.1K ﹤0.01% 7348
2021
Q2 		$163K Buy
1,766
+1,202
+213% +$76.7K ﹤0.01% 6223
2021
Q1 		$29K Buy
+564
New +$26.6K ﹤0.01% 6788
2020
Q3 		– Sell
-410
Closed -$6K – 6904
2020
Q2 		$6K Hold
410
– – ﹤0.01% 6528
2020
Q1 		$5K Buy
+410
New +$6.72K ﹤0.01% 6492
2019
Q2 		– Sell
-12,527
Closed -$258K – 7192
2019
Q1 		$258K Buy
12,527
+12,510
+73,588% +$216K ﹤0.01% 5402
2018
Q4 		$0 Buy
+17
New +$542 ﹤0.01% 7123
2018
Q3 		– Sell
-85
Closed -$3K – 7268
2018
Q2 		$3K Buy
+85
New +$3.75K ﹤0.01% 6862
2016
Q4 		– Sell
-8
Closed – – 7050
2016
Q3 		$0 Buy
8
+6
+300% +$447 ﹤0.01% 7118
2016
Q2 		$0 Buy
+2
New +$51 ﹤0.01% 7133
2015
Q3 		– Sell
-8
Closed – – 7219
2015
Q2 		$0 Buy
8
+7
+700% +$988 ﹤0.01% 7271
2015
Q1 		$0 Buy
+1
New +$218 ﹤0.01% 7086
2014
Q3 		– Sell
-22
Closed -$6K – 8006
2014
Q2 		$6K Buy
+22
New +$5.44K ﹤0.01% 7604

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return

Bank of America's CARM Position: Q4 2025 in Review

Bank of America sold out of Carisma Therapeutics (CARM) in Q4 2025, closing a stake of 1,398 shares — an estimated $383 sold.

Bank of America first reported a position in CARM in Q2 2014 and held it in 29 quarters. The position peaked at $381K in Q2 2023. 7 funds tracked by Wall St. Rank hold CARM as of Q4 2025.

  • Bank of America reported no remaining Carisma Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Bank of America sold 1,398 Carisma Therapeutics shares in Q4 2025, an estimated $383.
  • Bank of America first reported a position in Carisma Therapeutics in Q2 2014 and held it in 29 quarters.
  • Bank of America's Carisma Therapeutics position peaked at $381K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2025.

Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.